TABLE 1.
Horse no. | Virus strain | Virus dosea | Initial clinical diseaseb | Days postinfection at necropsy | Clinical status at necropsy | Viremia during acute diseasec |
---|---|---|---|---|---|---|
2084 | Wyo | 106 | Severe | 15 | Acute clinical | Yes |
2092 | Wyo | 101 | Severe | 22 | Acute clinical | Yes |
2079 | WSU5 | 106 | Mild | 29 | Acute clinical | Yes |
2085 | Wyo | 106 | Severe | 124 | Chronic clinical | Yes |
524 | Wyo | 103 | Severe | 879 | Subclinical | Yes |
489 | WSU5 | 106 | Mild | 665 | Subclinical | Yes |
498 | WSU5 | 106 | Mild | 726 | Subclinical | Yes |
EIAVWyo, horse infectious doses; EIAVWSU5, 50% tissue culture infectious doses.
Severe disease characterized by evidence of hemorrhagic diathesis.
Virus was detected by RT-PCR on plasma and/or virus isolation on neonatal equine kidney cells.